Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.44 |
| ▸ | IDO1 | P14902 | 2/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29845719 | 1.00 | MEN1 (0.46) | MEN1KMT2AUSP2ALDH1A1CYP1A2 | |
| SCHEMBL28925134 | 0.87 | MEN1 (0.40) | MEN1KMT2AUSP2ALDH1A1CYP1A2 | |
| SCHEMBL9748502 | 0.82 | ALDH1A1 (0.58) | MEN1KMT2AUSP2ALDH1A1CYP1A2 | |
| SCHEMBL1659997 | 0.81 | MAPT (0.46) | MEN1KMT2AUSP2ALDH1A1CYP1A2 | |
| SCHEMBL9748614 | 0.81 | TAAR1 (0.41) | MEN1KMT2AACHETAAR1IDO1 | |
| SCHEMBL27794492 | 0.80 | ALDH1A1 (0.45) | MEN1KMT2AUSP2ALDH1A1CYP1A2 | |
| SCHEMBL5280179 | 0.80 | CHRM2 (0.51) | MEN1KMT2AUSP2ALDH1A1CYP1A2 | |
| SCHEMBL9163007 | 0.80 | CYP1A2 (0.45) | MEN1KMT2AUSP2ALDH1A1CYP1A2 | |
| SCHEMBL14775953 | 0.80 | ALDH1A1 (0.45) | MEN1KMT2AUSP2ALDH1A1CYP1A2 | |
| SCHEMBL29941639 | 0.78 | ACHE (0.55) | MEN1KMT2AACHETAAR1IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2585569-A1 | PERFUME SYSTEMS | The Procter and Gamble Company (US) | 2013-05-01 | — | — | EP | claimed |
| US-8362303-B2 | Process for producing aromatic aldehyde compound | UFC CORPORATION (TW) | 2013-01-29 | — | — | US | claimed |
| US-20120264981-A1 | Process for Producing Aromatic Aldehyde Compound | UFC CORPORATION (TW) | 2012-10-18 | — | — | US | claimed |
| US-20120264975-A1 | Phase Transfer Catalyst for Producing Aromatic Aldehyde Compound | UFC CORPORATION (TW) | 2012-10-18 | — | — | US | claimed |
| WO-2011163337-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2011-12-29 | — | — | WO | claimed |
| US-20110308555-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE COMPANY, THE | 2011-12-22 | — | — | US | claimed |
| EP-2065360-A2 | 3-methylbenzyl isobutyrate | Symrise GmbH & Co. KG (DE) | 2009-06-03 | — | — | EP | claimed |
| US-20070191258-A1 | 3-Methylbenzyl-isobutyrate | SYMRISE GMBH & CO. KG (DE) | 2007-08-16 | — | — | US | claimed |
| EP-1747186-A1 | 3-METHYLBENZYL-ISOBUTYRAT | Symrise GmbH & Co. KG (DE) | 2007-01-31 | — | — | EP | claimed |
| WO-2005110967-A1 | 3-METHYLBENZYL-ISOBUTYRAT | SYMRISE GMBH & CO. KG (DE) | 2005-11-24 | — | — | WO | claimed |
| EP-4192614-B1 | PROCESS FOR THE PREPARATION OF MICROCAPSULES | SYMRISE AG (DE) | 2026-05-06 | — | — | EP | disclosed |
| US-12516147-B2 | Aldimines and uses thereof | BOSTIK SA (FR) | 2026-01-06 | — | — | US | disclosed |
| US-12421345-B2 | Polyimines and uses thereof | BOSTIK SA (FR) | 2025-09-23 | — | — | US | disclosed |
| US-20250144589-A1 | Method for Producing Microcapsules | SYMRISE AG (DE) | 2025-05-08 | — | — | US | disclosed |
| CN-116322326-B | Polyurea/polyurethane microcapsules | 西姆莱斯股份公司 | 2025-05-02 | — | — | CN | disclosed |
| WO-2005110967-A1 | 3-METHYLBENZYL-ISOBUTYRAT | SYMRISE GMBH & CO. KG (DE) | 2005-11-24 | — | — | WO | disclosed |
| WO-2003089394-A2 | METHOD FOR THE PRODUCTION OF PHENYL PROPYL ALCOHOLS | SYMRISE GMBH & CO. KG (DE) | 2003-10-30 | — | — | WO | disclosed |
| EP-0217159-B1 | ALDEHYDES, ACETALS, ALCOHOLS AND ETHERS WITH 3-METHYL OR 3,5-DIMETHYLBENZYL GROUPS, THEIR PREPARATION AND THEIR USE AS FRAGRANCE COMPOUNDS | Consortium für elektrochemische Industrie GmbH (DE) | 1992-01-02 | — | — | EP | disclosed |
| US-4710316-A | Aldehydes, acetals, alcohols and ethers having 3-methyl- or 3,5-dimethyl-benzyl groups, their manufacture and perfume materials containing same | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 1987-12-01 | — | — | US | disclosed |
| EP-0217159-A2 | Aldehydes, acetals, alcohols and ethers with 3-methyl or 3,5-dimethylbenzyl groups, their preparation and their use as fragrance compounds | Consortium für elektrochemische Industrie GmbH (DE) | 1987-04-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110308555-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | MEN1 3884/4885KMT2A 4669/4885USP2 1146/4885 |
| US-20120264975-A1 | Phase Transfer Catalyst for Producing Aromatic Aldehyde Compound | C9, TERT, ALKBH3 | MEN1 2243/4885KMT2A 416/4885USP2 3751/4885 |
| US-20120264981-A1 | Process for Producing Aromatic Aldehyde Compound | ALDH7A1, ALDH1A1, PAH | MEN1 4599/4885KMT2A 322/4885USP2 2766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.